Crispr Therapeutics Ag
USPTO Trademark & Patent Filings
Trademark applications and grants for Crispr Therapeutics Ag. Crispr Therapeutics Ag has 43 trademark applications. The latest application filed is for "CTX340"
- Company Aliases
- CRISPR Therapeutics AG
- ag therapeutics crispr
- CRISPR THERAPEUTICS AG - Zug CH
- CRISPR Therapeutics AG - Zug CH
Trademarks Patents
| Patent Application | Date |
|---|---|
| MATERIALS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS 20220290136 - 17/489218 Padmanabhan; Hari Kumar ; et al. | 2022-09-15 |
| GENETICALLY ENGINEERED T CELLS WITH PTPN2 KNOCKOUT HAVE IMPROVED FUNCTIONALITY AND ANTI-TUMOR ACTIVITY 20220288122 - 17/689071 Tetteh; Paul | 2022-09-15 |
| ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY ENGINEERED T CELLS TARGETING CD19 20220249558 - 17/607641 Benton; Mark ; et al. | 2022-08-11 |
| ANTI-CD33 IMMUNE CELL CANCER THERAPY 20220226375 - 17/291181 Terrett; Jonathan Alexander ; et al. | 2022-07-21 |
| UNIVERSAL DONOR CELLS 20220218760 - 17/566941 Rezania; Alireza ; et al. | 2022-07-14 |
| Universal donor cells 11,434,505 - 17/383,773 Rezania , et al. September 6, 2 | 2022-09-06 |
| Universal donor cells 11,433,103 - 17/383,760 Rezania , et al. September 6, 2 | 2022-09-06 |
| Universal donor cells 11,434,505 - 17/383,773 Rezania , et al. September 6, 2 | 2022-09-06 |
| Universal donor cells 11,433,103 - 17/383,760 Rezania , et al. September 6, 2 | 2022-09-06 |
| Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders 11,407,997 - 16/487,282 Lundberg , et al. August 9, 2 | 2022-08-09 |
| NCAGE Code | SVW87 | CRISPR THERAPEUTICS AG |
| CAGE Code | SVW87 | CRISPR THERAPEUTICS AG HEADQUARTERS |
| SEC | 0001674416 | CRISPR Therapeutics AG of SWITZERLAND |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 